PINK:XSNX

Xsunx Stock Insider Trading

Healthcare > Biotechnology

Buy XSNX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Xsunx Stock Insider Power

Based on the 88 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 36.34M and sold 3.66M XSNX shares in the last 88 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 88 transactions)	0
● Buy	36.34M shares
● Sell	3.66M shares
77% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 31, 2024 Buy	Convertible loan* A-Award	Cassarini John Director	Director	0 Value: $0
May 31, 2024 Buy	Convertible loan* A-Award	Cassarini John Director	Director	0 Value: $0
May 17, 2024 Buy	Common Stock	Sumner David 10 Percent Owner	10% Owner	0 Value: $0
May 17, 2024 Buy	Common Stock	Sumner David 10 Percent Owner	10% Owner	0 Value: $0
Mar 13, 2023 Buy	Stock Option (right to buy) A-Award	Anderson Jason Michael Director	Director	857 143 Value: $150.0K
Mar 13, 2023 Buy	Stock Option (right to buy) A-Award	Laird Neil J Chief Financial Officer	C-Suite Officer	428 571 Value: $75.0K
Mar 13, 2023 Buy	Stock Option (right to buy) A-Award	Anderson Jason Michael Director	Director	857 143 Value: $150.0K
Mar 13, 2023 Buy	Stock Option (right to buy) A-Award	Cassarini John Director	Director	857 143 Value: $150.0K
Mar 13, 2023 Buy	Stock Option (right to buy) A-Award	Laird Neil J Chief Financial Officer	C-Suite Officer	428 571 Value: $75.0K
Mar 13, 2023 Buy	Stock Option (right to buy) A-Award	Cassarini John Director	Director	857 143 Value: $150.0K
Mar 18, 2022 Buy	Common Stock, no par value	Anderson Jason Michael Director	Director	0 Value: $0
Mar 18, 2022 Buy	Common Stock, no par value	Anderson Jason Michael Director	Director	0 Value: $0
Mar 14, 2022 Buy	Common Stock, no par value	Cassarini John Director	Director	0 Value: $0
Mar 14, 2022 Buy	Common Stock, no par value	Cassarini John Director	Director	0 Value: $0
Mar 14, 2022 Buy	Series B Preferred Stock, $0.01 par value J-Other	Morris-irvin Dwain Chief Executive Officer	CEO / President	600 Value: $0
Mar 14, 2022 Buy	Common Stock, no par value J-Other	Martin Daniel G. 10 Percent Owner	10% Owner	1 502 670 Value: $375.7B
Mar 14, 2022 Buy	Series B Preferred Stock, $0.01 par value J-Other	Morris-irvin Dwain Chief Executive Officer	CEO / President	600 Value: $0
Mar 14, 2022 Sell	Series B Preferred Stock, $0.01 par value J-Other	Martin Daniel G. 10 Percent Owner	10% Owner	25 000 Value: $0
Mar 14, 2022 Sell	Series B Preferred Stock, $0.01 par value per share J-Other	Martin Daniel G.	Director	25 000 Value: $0
Mar 14, 2022 Sell	Series B Preferred Stock, $0.01 par value per share J-Other	Martin Daniel G. 10 Percent Owner	10% Owner	25 000 Value: $6.25B
Mar 14, 2022 Buy	Common Stock, no par value J-Other	Martin Daniel G. 10 Percent Owner	10% Owner	1 502 670 Value: $375.7B
Mar 14, 2022 Sell	Series B Preferred Stock, $0.01 par value J-Other	Martin Daniel G. 10 Percent Owner	10% Owner	25 000 Value: $0
Mar 14, 2022 Sell	Series B Preferred Stock, $0.01 par value per share J-Other	Martin Daniel G. 10 Percent Owner	10% Owner	25 000 Value: $6.25B
Mar 14, 2022 Sell	Series B Preferred Stock, $0.01 par value per share J-Other	Martin Daniel G.	Director	25 000 Value: $0
Jan 20, 2022 Buy	Common Stock, no par value P-Purchase	Laird Neil J Chief Financial Officer	C-Suite Officer	250 000 Value: $50.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT XSUNX INC

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio....

Read Full Profile Here